Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ENZ | Common Stock, $0.01 Par Value | Award | $0 | +39.1K | $0.00 | 39.1K | Apr 27, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ENZ | Stock Option (to acquire Common Stock) | 77.1K | Apr 27, 2022 | Common Stock | 77.1K | $2.63 | Direct | F2 |
Id | Content |
---|---|
F1 | The Reporting Person was granted Restricted Stock Units that will vest, subject to the individual continuing to serve as a member of the board of directors of Enzo Biochem, Inc., in two equal annual instalments, beginning on April 27, 2023. |
F2 | The stock options have a five-year term. Fifty percent of the stock options have vested, and the remaining fifty percent will vest on January 11, 2023. |